Ferumoxytol for Iron-Deficiency Anemia in Chronic Kidney Disease and Peritoneal Dialysis Patients
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy of ferumoxytol for the repletion of
iron stores and correction of iron deficiency anaemia in patients with severe chronic kidney
disease or end-stage chronic kidney disease on peritoneal dialysis, and to assess the impact
of the administration of a ferumoxytol dose on various markers for iron stores, as well as on
various markers for inflammation and oxidative stress.